Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study. - Snitker,S.; Watanabe,RM.; Ani,I.; Xiang,AH.; Marroquin,A.; Ochoa,C.; Goico,J.; Shuldiner,AR.; Buchanan,TA. (Diabetes Care, 2004)